Candid Therapeutics logo

Candid Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
21
Total Funding
$445M
Investors
21 investors across all rounds
BC
Boxer Capital
FP
Fairmount Partners
FM
Fidelity Management & Research Company
FC
Foresite Capital
FR
Franklin Resources

+16 more investors

Sign in to view all

Explore More Data
Detailed analysis for Candid Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

Candid Therapeutics Leadership & Investors

Candid Therapeutics is led by a team of experienced leaders. The company has attracted investment from 21 institutional and strategic investors.

Who Has Invested in Candid Therapeutics?

Candid Therapeutics has raised $445M from 21 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access Candid Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.